Effect of dietary iron overload in rat brain: Oxidative stress, neurotransmitter level and serum metal ion in relation to neurodegenerative disorders

Indian Journal of Experimental Biology

Volumn 46, Issue 12, 2008, Pages 855-858

  Elseweidy, Mohamed M ^a   El Baky, Atef E Abd ^b  

^a Biochemistry Departments   (Egypt)

^b MINIA UNIVERSITY   (Egypt)

Author keywords

Chromium; Dopamine; Ferrous sulphate; Iron; Serotonin; Zinc

Indexed keywords

RATTUS;

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DOPAMINE; SEROTONIN;

ANIMAL; ARTICLE; BLOOD; BRAIN; CHEMICALLY INDUCED DISORDER; DEGENERATIVE DISEASE; DRUG EFFECT; IRON INTAKE; MALE; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; BRAIN; DOPAMINE; IRON, DIETARY; MALE; NEURODEGENERATIVE DISEASES; NEUROTRANSMITTER AGENTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SEROTONIN;

EID: 67549115869     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moos T & Morgan E H, The metabolism of neuronal iron and its pathogenic role in neurological disease: Review, Ann NY Acad Sci, 1012, (2004)14.
2. Ponka P, Hereditary causes of disturbed iron homeostasis in the central nervous system, Ann N Y Acad Sci, 1012 (2004) 267.
3. Bishop G M, Robinson S R, Liu Q, Perry G, Atwood C S, & Smith, MA, Iron: A pathological mediator of Alzheimer disease? Dev Neurosci, 24, (2002) 184.
4. Kaur, D & Andersen, J, Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev, 3, (2004) 327.
5. Velez-Pardo C, Jimenez Del Rio M, Verschueren H, Ebinger G & Vanquelin G, Dopamine and iron induce apoptosis in PC12 cells, Pharmacol Toxicol, 80(2) (1997) 76
6. Castellanos M, Puig N, Carbonell T, Castillo J, Martinez J, Rama R & Davalos A, Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats, Brain Res, 11, 952(1) (2002) 1.
7. Sandstead H H, Understanding zinc: Recent observations and interpretations, J Lab Clin Med, 124 (1994) 322.
8. Fabris N & Mocchegiani E, Zinc, human diseases and aging, Aging (Milano), 7 (1995) 77.
9. Heyneman C A, Zinc deficiency and taste disorders, Ann Pharmacother, 30 (1996) 186.
10. Prasad A S, Zinc: An overview, Nutrition, 11 (1995) 93.
11. Simmer K & Thompson R P, Zinc in the fetus and newborn, Acta Paediatr Scand SUPPL., 319 (1985) 158.
12. Solomons N W, Mild human zinc deficiency produces an imbalance between cell-mediated and humoral immunity, Nutr Rev, 56 (1998) 27.
13. Vincent J B, Elucidating a biological role for Chromium at a molecular level, Acc Chem Res, 33 (2000a) 503.
14. Vincent JB, Quest for the molecular mechanism of Chromium action and its relationship to diabetes, Nutr Rev, 58 (2000b) 67.
15. Vincent, JB, The bioinorganic chemistry of Chromium (III), Polyhedron, 20 (2001)1.
16. Shahidi, F & Naczk, M, in Phenolics in food and nutraceuticals, 2nd Edition, (CRC Press, Boca Raton, Florida) 2003.
17. Schemer-S, The blood morphology of laboratory animals, 3rd edition (Davis-F A Company, Pheladephia, U S A) 1967, 42.
18. Schlumpf M, Lichtensteiger W, Langemann H, Waser P G & Hefti F A, fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milli gram amounts of brain tissue, Biochem Pharm, 23 (1973) 2337.
19. Jain S K, Hyperglycemia can cause membrane lipid peroxidaton and osmotic fragility in human red blood cells, J Biol Chem, 264 (1989) 21340.
20. Janero D R, Malondialdhyde and thiobarbituric acidreactivity as diagnostic indeces of lipid peroxidation and peroxidative tissue injury, Free Rad Biol Med, 9 (1990) 515.
21. Usovich A T, Lavrik N G & Mamchich A P, Use of flame photometry for the determination of sodium and potassium, Veterinariia (USSR), (1975) 111.
22. Jimenez DeL Rio M, Velez Pardo C, Pinxteren J, De Potter W, Ebinger G & Vauquelin G, Binding of serotonin and dopamine to 'serotonin binding proteins' in bovine frontal cortex: evidence for iron-induced oxidative mechanisms, Eur J Pharmacol, 15, 247(1) (1993) 11.
23. Nagy K, Floyd R A, Simon P & Nagy I, Studies on the effect of iron overload on rat cortex synaptosomal membranes, Biochim Biophys Acta, 7, 820(2) (1985) 216.
24. Velez-Pardo C, Del Rio M J, Ebinger G & Vauquelin G, Monoamine and iron-related toxicity from "serotonin binding proteins" to lipid peroxidation and apoptosis in PC12 cells, Gen Pharmacol, 31(1) (1998) 19.
25. Kuhn DM & Arthur R Jr, Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons, J Neurosci, 15, 18(18) (1998) 7111.
26. Park J W, Youn Y C, Kwon O S, Jang Y Y, Han E S & Lee C S, Protective effect of serotonin on 6-hydroxydopamineand dopamine-induced oxidative damage of brain mitochondria and synaptosomes and PC12 cells, Neurochem Int, 40(3) (2002) 223.
27. Burke W J, Li S W, Chung H D, Ruggiero D A, Kristal B S, Johnson E M, Lampe P, Kumar V B, Franko M,Williams E A & Zahm D S, Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases, Neurotoxicology, 25 (1-2) (2004) 101.
28. Mario E. Götz, Kay Double, Manfred Gerlach, Mmoussa B H, Youdim & Peter Riederere, The relevance of iron in the pathogenesis of Parkinson's disease. Redox-active metals in neurological disorders, Ann NY Acad Sci, 1012 (2004) 193